Salk Institute

Technologies Available for Licensing

New Tumor Mouse Models Using CRE Inducible Lentiviral Vectors

Inventors: Yasushi Soda, Tomotoshi Marumoto, & Inder Verma
Potential Uses: Use of Cre-loxP-controlled lentiviral vectors to generate a mouse cancer model(s) in a region- and cell type-specific manner in adult mice. Such models can be used for drug development & biological analysis of tumor development.

Cre recombinase-dependent expression of the recombinant oncogene (Flag H-RasV12) expessed with green fluorescent protein (Green Image) in the hippocampus of GFAP-Cre mice.

We have developed a mouse using CRE Inducible Lentiviral Vectors to induce cell-specific or region-specific oncogene expression. Our initial work has provided a new method to induce glioblastoma multiforme in adult immunocompetent mice by injecting Cre-loxP-controlled lentiviral vectors expressing oncogenes. Cell type- or region-specific expression of activated forms of the oncoproteins Harvey-Ras and AKT in fewer than 60 glial fibrillary acidic protein-positive cells in the hippocampus, subventricular zone or cortex of mice heterozygous for the gene encoding the tumor suppressor Tp53 were developed. Mice developed glioblastoma multiforme when transduced either in the subventricular zone or the hippocampus. Transplantation of brain tumor cells into naive recipient mouse brain resulted in the formation of glioblastoma multiforme-like tumors, which contained CD133+ cells, formed tumorspheres and could differentiate into neurons and astrocytes. The use of Cre-loxP-controlled lentiviral vectors is a novel way to generate a mouse glioblastoma multiforme model in a region- and cell type-specific manner in adult mice. Thes models can be used for drug development and biological analysis of tumor development.


Salk No: S07006B
Patent Status: Published PCT Application WO28109127
U.S. Patent Application published as 2008/0292591
Publications: Nature Medicine 15, 110 - 116 (2008)
Press Release: Salk researchers develop novel glioblastoma mouse model
License Terms: Non-exclusive and Exclusive by Field of Use Licenses Negotiable
Contact: Michelle Booden, Ph.D., Director of Licensing, 858.453.4100 x1612,

Get Involved

Sign up for our email newsletter

Fill out my online form.
Salk Institute for Biological Studies
Street: 10010 N Torrey Pines Rd
City: La Jolla, CA 92037
Phone: 858.453.4100
Charity Navigator Rating
  • Salk Twitter
  • Salk LinkedIn
  • Salk Facebook
  • Salk Instagram
  • Salk Google+
  • Salk YouTube
  • Salk RSS Feed
© Copyright 2015 Salk Institute for Biological Studies | Privacy Policy About Scientists & Research News & Media Events Support